View of Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand | Journal of Population Therapeutics and Clinical Pharmacology

Return to Article Details Regulatory approval and public drug plan listing of new drugs for rare disorders in Canada and New Zealand